Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EBP | Q15125 | 2/20 | 0.34 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.34 |
| ▸ | TACR1 | P25103 | 4/20 | 0.31 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.31 |
| ▸ | UBE2M | P61081 | 4/20 | 0.31 |
| ▸ | DCUN1D1 | Q96GG9 | 4/20 | 0.31 |
| ▸ | CCR2 | P41597 | 1/20 | 0.31 |
| ▸ | GPR52 | Q9Y2T5 | 1/20 | 0.30 |
| ▸ | DPP4 | P27487 | 1/20 | 0.30 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.30 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.30 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.30 |
| ▸ | CETP | P11597 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7311104 | 0.95 | EBP (0.35) | EBPSIGMAR1TACR1CACNA1BEPHX1 | |
| SCHEMBL7307707 | 0.95 | EBP (0.36) | EBPSIGMAR1CACNA1B | |
| SCHEMBL7316004 | 0.92 | EPHX1 (0.37) | EBPSIGMAR1EPHX1DPP4DPP8 | |
| SCHEMBL7310134 | 0.90 | EBP (0.37) | EBPSIGMAR1CACNA1BDPP4DPP8 | |
| SCHEMBL7317799 | 0.90 | EBP (0.36) | EBPSIGMAR1CACNA1BDPP4DPP8 | |
| SCHEMBL7309476 | 0.89 | EBP (0.36) | EBPSIGMAR1CACNA1B | |
| SCHEMBL7306036 | 0.88 | EBP (0.41) | EBPSIGMAR1CACNA1B | |
| SCHEMBL7311941 | 0.88 | EBP (0.36) | EBPSIGMAR1CACNA1B | |
| SCHEMBL7317926 | 0.87 | EBP (0.35) | EBPSIGMAR1CACNA1B | |
| SCHEMBL7313956 | 0.87 | CACNA1B (0.32) | EBPSIGMAR1CACNA1BEPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1041064-A2 | N-substituted alpha aminoacid amides as calcium channel modulators | ELI LILLY AND COMPANY LIMITED (GB) | 2000-10-04 | — | — | EP | disclosed |
| EP-0805147-A1 | Novel N-substituted alpha aminoacid amides as calcium channel modulators | LILLY INDUSTRIES LIMITED (GB) | 1997-11-05 | — | — | EP | disclosed |